A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.

The National Coalition for Cancer Survivorship’s newest State of Survivorship report provides insights into the experiences ...

South Florida cervical cancer survivors offer help, support to women dealing with it 02:54. MIAMI -- The fight to end cervical cancer endures all year long, but during January the ...

The unsuccessful Phase III results are the latest to suggest that the blockbuster cancer drug is finally bumping up against ...

Cancer rates are declining, but young women are being diagnosed more frequently. Learn about the current trends and research ...

A study showed that modifications make the laparoscopic procedure viable, but an editorialist urges caution in use outside ...

After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...

Incidences for many common types of cancer have risen in recent years, with young women experiencing the brunt of the shift.

Obesity, poor diet, and inactive lifestyles are contributing to higher cancer rates among young and middle-aged women.

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

all patients with primary advanced or recurrent endometrial cancer in the EU have an approved immuno-oncology-based treatment ...

GSK plc GSK announced that the European Commission has granted approval for the expanded use of Jemperli (dostarlimab) plus ...